The team behind TOXsIgN has invested considerable time, resources, and effort into collecting, curating, processing, developing, and maintaining this web resource. Please follow the citation guidelines if you are using it.
×
TSP48519-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K13274297 TSA198584-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 TSA198630-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 TSA198682-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 TSA198732-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 TSA198783-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 TSA198835-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 TSA198883-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 TSA198928-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 TSF399762-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 10.0 µM for 24.0 h 1 subfactor(s) TSF399763-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 3.33 µM for 24.0 h 1 subfactor(s) TSF399765-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.37 µM for 24.0 h 1 subfactor(s) TSF399764-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 1.11 µM for 24.0 h 1 subfactor(s) TSF399766-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.125 µM for 24.0 h 1 subfactor(s) TSF399767-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.04 µM for 24.0 h 1 subfactor(s) TSF400077-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 10.0 µM for 24.0 h 1 subfactor(s) TSF400078-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 3.33 µM for 24.0 h 1 subfactor(s) TSF400079-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 1.11 µM for 24.0 h 1 subfactor(s) TSF400080-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.37 µM for 24.0 h 1 subfactor(s) TSF400081-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.125 µM for 24.0 h 1 subfactor(s) TSF400082-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.04 µM for 24.0 h 1 subfactor(s) TSF400394-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 10.0 µM for 24.0 h 1 subfactor(s) TSF400399-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.04 µM for 24.0 h 1 subfactor(s) TSF400395-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 3.33 µM for 24.0 h 1 subfactor(s) TSF400396-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 1.11 µM for 24.0 h 1 subfactor(s) TSF400397-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.37 µM for 24.0 h 1 subfactor(s) TSF400398-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.125 µM for 24.0 h 1 subfactor(s) TSF400711-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 1.11 µM for 24.0 h 1 subfactor(s) TSF400712-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.37 µM for 24.0 h 1 subfactor(s) TSF400709-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 10.0 µM for 24.0 h 1 subfactor(s) TSF400710-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 3.33 µM for 24.0 h 1 subfactor(s) TSF400713-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.125 µM for 24.0 h 1 subfactor(s) TSF400714-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.04 µM for 24.0 h 1 subfactor(s) TSF401026-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 3.33 µM for 24.0 h 1 subfactor(s) TSF401025-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 10.0 µM for 24.0 h 1 subfactor(s) TSF401027-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 1.11 µM for 24.0 h 1 subfactor(s) TSF401028-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.37 µM for 24.0 h 1 subfactor(s) TSF401029-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.125 µM for 24.0 h 1 subfactor(s) TSF401030-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.04 µM for 24.0 h 1 subfactor(s) TSF401347-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.125 µM for 24.0 h 1 subfactor(s) TSF401343-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 10.0 µM for 24.0 h 1 subfactor(s) TSF401344-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 3.33 µM for 24.0 h 1 subfactor(s) TSF401345-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 1.11 µM for 24.0 h 1 subfactor(s) TSF401346-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.37 µM for 24.0 h 1 subfactor(s) TSF401348-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.04 µM for 24.0 h 1 subfactor(s) TSF401663-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 10.0 µM for 24.0 h 1 subfactor(s) TSF401664-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 3.33 µM for 24.0 h 1 subfactor(s) TSF401665-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 1.11 µM for 24.0 h 1 subfactor(s) TSF401666-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.37 µM for 24.0 h 1 subfactor(s) TSF401667-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.125 µM for 24.0 h 1 subfactor(s) TSF401668-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.04 µM for 24.0 h 1 subfactor(s) TSF401982-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.04 µM for 24.0 h 1 subfactor(s) TSF401978-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 3.33 µM for 24.0 h 1 subfactor(s) TSF401977-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 10.0 µM for 24.0 h 1 subfactor(s) TSF401979-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 1.11 µM for 24.0 h 1 subfactor(s) TSF401980-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.37 µM for 24.0 h 1 subfactor(s) TSF401981-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.125 µM for 24.0 h 1 subfactor(s) TSS399770-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 10.0 µM for 24.0 h TSS399771-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 3.33 µM for 24.0 h TSS399773-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.37 µM for 24.0 h TSS399772-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 1.11 µM for 24.0 h TSS399774-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.125 µM for 24.0 h TSS399775-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A375 after exposure to BRD-K13274297 0.04 µM for 24.0 h TSS400085-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 10.0 µM for 24.0 h TSS400086-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 3.33 µM for 24.0 h TSS400087-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 1.11 µM for 24.0 h TSS400088-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.37 µM for 24.0 h TSS400089-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.125 µM for 24.0 h TSS400090-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line A549 after exposure to BRD-K13274297 0.04 µM for 24.0 h TSS400402-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 10.0 µM for 24.0 h TSS400407-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.04 µM for 24.0 h TSS400403-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 3.33 µM for 24.0 h TSS400404-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 1.11 µM for 24.0 h TSS400405-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.37 µM for 24.0 h TSS400406-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HA1E after exposure to BRD-K13274297 0.125 µM for 24.0 h TSS400719-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 1.11 µM for 24.0 h TSS400720-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.37 µM for 24.0 h TSS400717-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 10.0 µM for 24.0 h TSS400718-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 3.33 µM for 24.0 h TSS400721-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.125 µM for 24.0 h TSS400722-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HCC515 after exposure to BRD-K13274297 0.04 µM for 24.0 h TSS401034-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 3.33 µM for 24.0 h TSS401033-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 10.0 µM for 24.0 h TSS401035-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 1.11 µM for 24.0 h TSS401036-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.37 µM for 24.0 h TSS401037-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.125 µM for 24.0 h TSS401038-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HEPG2 after exposure to BRD-K13274297 0.04 µM for 24.0 h TSS401355-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.125 µM for 24.0 h TSS401351-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 10.0 µM for 24.0 h TSS401352-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 3.33 µM for 24.0 h TSS401353-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 1.11 µM for 24.0 h TSS401354-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.37 µM for 24.0 h TSS401356-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line HT29 after exposure to BRD-K13274297 0.04 µM for 24.0 h TSS401671-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 10.0 µM for 24.0 h TSS401672-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 3.33 µM for 24.0 h TSS401673-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 1.11 µM for 24.0 h TSS401674-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.37 µM for 24.0 h TSS401675-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.125 µM for 24.0 h TSS401676-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line MCF7 after exposure to BRD-K13274297 0.04 µM for 24.0 h TSS401990-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.04 µM for 24.0 h TSS401986-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 3.33 µM for 24.0 h TSS401985-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 10.0 µM for 24.0 h TSS401987-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 1.11 µM for 24.0 h TSS401988-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.37 µM for 24.0 h TSS401989-CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures in the human cell line PC3 after exposure to BRD-K13274297 0.125 µM for 24.0 h
TSP48519 - CMap - Expanded CMap LINCS Resource 2020: Toxicogenomic signatures after exposure to BRD-K13274297
Public
https://clue.io/data/CMap2020#LINCS2020
Experimental design
No experimental design provided
Results
No results provided